<DOC>
	<DOCNO>NCT00728728</DOCNO>
	<brief_summary>This study investigate adjunctive pregnenolone patient schizophrenia schizoaffective disorder .</brief_summary>
	<brief_title>Pregnenolone Cognitive Negative Symptoms Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<criteria>Diagnosis : DSMIV/DSMIV TR schizophrenia schizoaffective disorder ; Gender : Males Females ; Age : 2165 ; Caucasian Non Caucasian ; Capable providing informed consent ; Duration illness equal great one year ; No change antipsychotic medication previous eight week , change antipsychotic dose previous four week ; No benzodiazepine use past twelve hour prior cognitive testing ; The patient cohort enrich cognitive symptom ( Composite BACS score = 03 standard deviation mean , assess screen visit ) . Subjects DSMIV/DSMIV TR diagnosis alcohol substance dependence ( nicotine ) within last month ; Subjects history significant head injury/trauma , define one following : Loss consciousness ( LOC ) 1 hour , Recurring seizure result head injury , Clear cognitive sequela injury , Cognitive rehabilitation follow injury ; Subjects unstable medical illness neurological illness ( seizure , CVA ) ; Patients hormonesensitive tumor ( breast , uterine , prostate cancer ) ; Clinically significant abnormality physical examination , ECG , laboratory assessment ; Pregnant woman woman childbearing potential , either surgicallysterile use appropriate method birth control ( serum betahuman chorionic gonadotropin [ HCG ] perform baseline , 4 week , 8 week exclude pregnancy ) ; Women breastfeeding ; Electroconvulsive therapy ( ECT ) treatment within last 3 month ; Use oral contraceptive hormonal supplementation estrogen . Although early study suggest effect menstrual cycle , alteration downstream metabolites pregnenolone ( estradiol ) could theoretically impact efficacy oral contraceptive and/or estrogen replacement . Similarly , theoretically possible pregnenolone could metabolize steroid , result hair , skin , steroidrelated change . Since determine prior study pregnenolone administration result downstream elevation DHEA , DHEAS , estradiol , testosterone , possibility may unlikely ; Current active suicidal and/or homicidal ideation , intent , plan ; Known allergy study medication .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>pregnenolone</keyword>
	<keyword>schizophrenia</keyword>
	<keyword>cognitive</keyword>
	<keyword>positive symptom</keyword>
	<keyword>negative symptom</keyword>
	<keyword>placebo control</keyword>
</DOC>